Handelsbanken Fonder’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,200
Closed -$223K 1566
2024
Q3
$223K Hold
14,200
﹤0.01% 1479
2024
Q2
$192K Hold
14,200
﹤0.01% 1489
2024
Q1
$393K Hold
14,200
﹤0.01% 1278
2023
Q4
$274K Hold
14,200
﹤0.01% 1411
2023
Q3
$229K Hold
14,200
﹤0.01% 1415
2023
Q2
$270K Buy
14,200
+900
+7% +$16.1K ﹤0.01% 1383
2023
Q1
$194K Hold
13,300
﹤0.01% 1459
2022
Q4
$260K Hold
13,300
﹤0.01% 1323
2022
Q3
$321K Hold
13,300
﹤0.01% 1214
2022
Q2
$418K Buy
13,300
+1,500
+13% +$54.3K ﹤0.01% 1131
2022
Q1
$519K Sell
11,800
-5,300
-31% -$228K ﹤0.01% 1178
2021
Q4
$744K Sell
17,100
-1,900
-10% -$74.5K ﹤0.01% 1076
2021
Q3
$595K Buy
19,000
+1,000
+6% +$39.4K ﹤0.01% 1238
2021
Q2
$762K Buy
18,000
+4,800
+36% +$187K ﹤0.01% 1077
2021
Q1
$496K Hold
13,200
﹤0.01% 1206
2020
Q4
$357K Buy
+13,200
New +$340K ﹤0.01% 1330

Other funds holding ACH

Handelsbanken Fonder's ACH Position: Q4 2024 in Review

Handelsbanken Fonder sold out of Accendra Health (ACH) in Q4 2024, closing a stake of 14,200 shares — an estimated $223K sold.

Handelsbanken Fonder first reported a position in ACH in Q4 2020 and held it in 16 quarters. The position peaked at $762K in Q2 2021. 198 funds tracked by Wall St. Rank hold ACH as of Q4 2024.

  • Handelsbanken Fonder reported no remaining Accendra Health position as of Q4 2024 after selling out during the quarter.
  • Handelsbanken Fonder sold 14,200 Accendra Health shares in Q4 2024, an estimated $223K.
  • Handelsbanken Fonder first reported a position in Accendra Health in Q4 2020 and held it in 16 quarters.
  • Handelsbanken Fonder's Accendra Health position peaked at $762K in Q2 2021.
  • 198 funds tracked by Wall St. Rank held Accendra Health as of Q4 2024.

Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.